Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia

Autor: Amandine Hl Truong, Barry Zochodne, Kendra Stetler, Yaacov Ben-David, Daniel J. Dumont, Jeffrey C. Howard, Rachel R. Higgins, Stuart A. Berger
Rok vydání: 2000
Předmět:
Cancer Research
Cellular differentiation
Stem cell factor
Mice
Phosphatidylinositol 3-Kinases
chemistry.chemical_compound
Viral Envelope Proteins
hemic and lymphatic diseases
Receptors
Erythropoietin

STAT5 Transcription Factor
Tumor Cells
Cultured

Erythropoiesis
Phosphorylation
Mice
Inbred BALB C

Stem Cell Factor
Cell Differentiation
Milk Proteins
Friend murine leukemia virus
Cell biology
DNA-Binding Proteins
Signal transduction
Cell Division
Signal Transduction
medicine.drug
medicine.medical_specialty
Src Homology 2 Domain-Containing
Transforming Protein 1

Biology
Proto-Oncogene Proteins
Internal medicine
Genetics
medicine
Animals
Humans
Erythropoietin
Molecular Biology
Adaptor Proteins
Signal Transducing

Proto-Oncogene Protein c-fli-1
Cell growth
Proteins
Tyrosine phosphorylation
Adaptor Proteins
Vesicular Transport

Endocrinology
Shc Signaling Adaptor Proteins
chemistry
Cell culture
Trans-Activators
ras Proteins
Leukemia
Erythroblastic
Acute
Zdroj: Oncogene. 19:2296-2304
ISSN: 1476-5594
0950-9232
Popis: We have recently isolated the erythroleukemic cell line, HB60-5, that proliferates in the presence of erythropoietin (Epo) and stem cell factor (SCF), but undergoes terminal differentiation in the presence of Epo alone. Ectopic expression of the ets related transcription factor Fli-1 in these cells resulted in the establishment of the Epo-dependent cell line HB60-ED that proliferates in the presence of Epo. In this study, we utilized these two cell lines to examine the signal transduction pathways that are activated in response to Epo and SCF stimulation. We demonstrate that Epo, but not SCF, phosphorylates STAT-5 in both HB60-5 and HB60-ED cells. Interestingly, SCF activates the Shc/ras pathway in HB60-5 cells while Epo does not. However, both Epo and SCF are capable of activating the Shc/ras pathway in HB60-ED cells. Furthermore, enforced expression of gp55 in HB60-5 cells by means of infection with the Spleen Focus Forming virus-P (SFFV-P), confers Epo independent growth, which is associated with the up-regulation of Fli-1. Activation of the Shc/ras pathway is readily detected in gp55 expressing cells in response to both Epo and SCF, and is associated with a block in STAT-5B tyrosine phosphorylation. These results suggest that STAT-5 activation, in the absence of Shc/ras activation, plays a role in erythroid differentiation. Moreover, Fli-1 is capable of switching Epo-induced differentiation to Epo-induced proliferation, suggesting that this ets factor regulated genes whose products modulate the Epo-Epo-R signal transduction pathway.
Databáze: OpenAIRE